drugset / Trial / NCT06321198
A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD
Recruiting
12 enrolled
Anhui Provincial Hospital
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS) · collab
NaSingle-groupOpen-labelTreatment
Summary
A study to evaluate the safety and preliminary efficacy of iMSC in subjects with SR-aGVHD
Timeline
- Start
- 2024-02-10
- Primary completion
- 2027-03-02
- Completion
- 2027-03-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | iMSC | Cell therapy | — | Other |